<code id='25ABC9572A'></code><style id='25ABC9572A'></style>
    • <acronym id='25ABC9572A'></acronym>
      <center id='25ABC9572A'><center id='25ABC9572A'><tfoot id='25ABC9572A'></tfoot></center><abbr id='25ABC9572A'><dir id='25ABC9572A'><tfoot id='25ABC9572A'></tfoot><noframes id='25ABC9572A'>

    • <optgroup id='25ABC9572A'><strike id='25ABC9572A'><sup id='25ABC9572A'></sup></strike><code id='25ABC9572A'></code></optgroup>
        1. <b id='25ABC9572A'><label id='25ABC9572A'><select id='25ABC9572A'><dt id='25ABC9572A'><span id='25ABC9572A'></span></dt></select></label></b><u id='25ABC9572A'></u>
          <i id='25ABC9572A'><strike id='25ABC9572A'><tt id='25ABC9572A'><pre id='25ABC9572A'></pre></tt></strike></i>

          Home / hotspot / explore

          explore


          explore

          author:fashion    Page View:31374
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In